BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patients

Associations of statin use with glycaemic traits and incident type 2 diabetes

Pharmacological management of X-linked hypophosphataemia.

Increased risk of mycotic infections associated with sodium–glucose co‐transporter 2 inhibitors: a prescription sequence symmetry analysis

Liraglutide treatment reduced interleukin‐6 in adults with type 1 diabetes but did not improve established autonomic or polyneuropathy

Clinical and translational pharmacology of drugs for the prevention and treatment of bone metastases and cancer-induced bone loss.

Pharmacist services in nursing homes: A systematic review and meta‐analysis

Optimising Low Dose Methotrexate for Rheumatoid Arthritis - A Review.

Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population‐based cohort study

Optimizing the dose in patients treated with imatinib as first line treatment for gastrointestinal stromal tumours: A cost‐effectiveness study

Outcomes of deprescribing interventions in older patients with life‐limiting illness and limited life expectancy: A systematic review

Dose‐linearity of the pharmacokinetics of an intravenous [14C]midazolam microdose in children

Parasitic pharmacology: A plausible mechanism of action for cannabidiol

Fluid volume kinetics of 20% albumin

Development of a physiologically based pharmacokinetic model for mefloquine and its application alongside a clinical effectiveness model to select an optimal dose for prevention of malaria in young Caucasian children

Haematological adverse events associated with tyrosine kinase inhibitors in chronic myeloid leukaemia: A network meta‐analysis

Diabetes mellitus comorbidity in patients enrolled in tuberculosis drug efficacy trials around the world: A systematic review

Comparison of pharmacokinetics and the exposure–response relationship of dapagliflozin between adolescent/young adult and adult patients with type 1 diabetes mellitus

Predicting the dose of vancomycin in ICU patients receiving different types of RRT therapy: a model-based meta-analytic approach.

A phase 1/1b study of PUR1900, an inhaled formulation of itraconazole, in healthy volunteers and asthmatics to study safety, tolerability and pharmacokinetics

Translating the dose response into risk and benefit.

Understanding the UK Psychoactive Substances Act.

Body of evidence and approaches applied in the clinical development programme of fixed‐dose combinations in the European Union from 2010 to 2016

The rationale of dose-response curves in selecting cancer drug dosing.

Maturational changes in vancomycin protein binding affect vancomycin dosing in neonates

High-risk medicines associated with clinically relevant medication-related problems in United Kingdom hospitals: a prospective observational study.

Pharmacokinetic–pharmacodynamic (dipeptidyl peptidase‐4 inhibition) model to support dose rationale in diabetes patients, including those with renal impairment, for once‐weekly administered omarigliptin

Heuristics for designing user‐centric drug products: Lessons learned from Human Factors and Ergonomics

Misuse of benzodiazepines: Prevalence and impact in an inpatient population with psychiatric disorders

Treatment of exudative age‐related macular degeneration with aflibercept combined with pranoprofen eye drops or nutraceutical support with omega‐3: A randomized trial

Central nervous system effects of the histamine‐3 receptor antagonist CEP‐26401, in comparison with modafinil and donepezil, after a single dose in a cross‐over study in healthy volunteers

Conference report: pharmacogenomics in special populations at WCP2018

Pharmacokinetics and safety of tobramycin nebulization with the I‐neb and PARI‐LC Plus in children with cystic fibrosis: A randomized, crossover study

Pharmacoepidemiology: Using randomised control trials and observational studies in clinical decision‐making

Using human experience to identify drug repurposing opportunities: theory and practice

Target engagement and cellular fate of otelixizumab: a repeat dose escalation study of an anti‐CD3ε mAb in new‐onset type 1 diabetes mellitus patients

Statins popularity: A global picture

Adjusted indirect comparisons to assess bioequivalence between generic clopidogrel products in Serbia

Overuse or underuse of methylphenidate in adults in France: commentary on Pauly et al. 2018

Evaluating metronidazole as a novel, safe CYP2A6 phenotyping probe in healthy adults

Efficacy, safety and pharmacokinetics of ilaprazole infusion in healthy subjects and patients with esomeprazole as positive control

Therapeutic drug monitoring of infliximab in spondyloarthritis. A review of the literature.

Clinical and pharmacokinetics equivalence of multiple doses of levodopa benserazide generic formulation vs the originator (Madopar)

Dynamics of circulating vascular endothelial growth factor‐A predict benefit from antiangiogenic cediranib in metastatic or recurrent cervical cancer patients

The interaction between rifampicin and lamotrigine: A case report

Why dose adjust systemic exposure when looking for associations with adverse events in tacrolimus‐treated transplant recipients?

Adrenal gland-released Vasostatin-I is a myocardial depressant factor.